Analytical Data
-
基因名
AADAC
- Application
-
别名
AADAC；DAC；Arylacetamide deacetylase
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
P22760
-
表达区间
24-399aa
-
氨基酸序列
PDNVEEPWRMMWINAHLKTIQNLATFVELLGLHHFMDSFKVVGSFDEVPP TSDENVTVTETKFNNILVRVYVPKRKSEALRRGLFYIHGGGWCVGSAALS GYDLLSRWTADRLDAVVVSTNYRLAPKYHFPIQFEDVYNALRWFLRKKVL AKYGVNPERIGISGDSAGGNLAAAVTQQLLDDPDVKIKLKIQSLIYPALQ PLDVDLPSYQENSNFLFLSKSLMVRFWSEYFTTDRSLEKAMLSRQHVPVE SSHLFKFVNWSSLLPERFIKGHVYNNPNYGSSELAKKYPGFLDVRAAPLL ADDNKLRGLPLTYVITCQYDLLRDDGLMYVTRLRNTGVQVTHNHVEDGFH GAFSFLGLKISHRLINQYIEWLKENL
-
分子量
63 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
AADAC (adipocyte-derived adrenal antagonistic peptide) is a protein that has garnered significant interest in the field of biochemistry and molecular biology due to its potential roles in metabolic regulation and disease modulation. Initially identified as a secreted protein from adipocytes, AADAC is thought to play a crucial role in lipid metabolism and energy homeostasis. Research has indicated that AADAC may interact with various metabolic pathways, influencing processes such as glucose homeostasis and insulin sensitivity. Furthermore, its involvement in inflammation and cardiovascular diseases has sparked curiosity about its therapeutic potential. The recombinant expression of AADAC allows for detailed studies of its structure-function relationships and interactions with other biomolecules, facilitating the exploration of its physiological roles. Advances in protein engineering and expression systems have enabled researchers to produce AADAC in a more efficient and cost-effective manner, which is critical for high-throughput screening and functional assays. Understanding the mechanisms by which AADAC operates could offer insights into potential applications in therapies for metabolic disorders and obesity-related conditions, making it a promising target for future research. The continued investigation of AADAC as a recombinant protein highlights the significance of post-translational modifications and the need for further studies to elucidate its biological functions and clinical relevance.
